{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:39:55Z","timestamp":1777628395789,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,19]],"date-time":"2027-02-19T00:00:00Z","timestamp":1802995200000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.xphs.2026.104209","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T23:30:02Z","timestamp":1771111802000},"page":"104209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted transdermal scopolamine delivery over the salivary glands for sialorrhea: Dose\u2013response and systemic safety in rats"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3011-3714","authenticated-orcid":false,"given":"Natsuko","family":"Ishida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Takagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsumi","family":"Urayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yui","family":"Kishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manaka","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4639-3510","authenticated-orcid":false,"given":"Rikako","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1817-5765","authenticated-orcid":false,"given":"Satoshi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6773-7646","authenticated-orcid":false,"given":"Hiroshi","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Suga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.xphs.2026.104209_bib0001","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3390\/toxins16080366","article-title":"Real-world observational analysis of clinical characteristics and treatment patterns of patients with chronic sialorrhea","volume":"16","author":"Hast","year":"2024","journal-title":"Toxins"},{"key":"10.1016\/j.xphs.2026.104209_bib0002","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jocn.2023.07.013","article-title":"Comparison of factors associated with drooling between intractable neuromuscular disease and cerebral palsy","volume":"115","author":"Ishida","year":"2023","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.xphs.2026.104209_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.113764","article-title":"A descriptive study of 10-year clozapine use from the nationwide database in Japan","volume":"297","author":"Toyoda","year":"2021","journal-title":"Psychiatry Res"},{"issue":"6","key":"10.1016\/j.xphs.2026.104209_bib0004","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/JCP.0000000000001917","article-title":"Clozapine-associated sialorrhea: a literature review","volume":"44","author":"G\u00fcrcan","year":"2024","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104209_bib0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/practneurol-2016-001515","article-title":"Management of oral secretions in neurological disease","volume":"17","author":"McGeachan","year":"2017","journal-title":"Pract Neurol"},{"issue":"11","key":"10.1016\/j.xphs.2026.104209_bib0006","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/dmcn.14316","article-title":"Prevalence of drooling, swallowing, and feeding problems in cerebral palsy across the lifespan: a systematic review and meta-analyses","volume":"61","author":"Speyer","year":"2019","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.xphs.2026.104209_bib0007","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000358793","article-title":"Drooling","volume":"24","author":"Silvestre-Donat","year":"2014","journal-title":"Monogr Oral Sci"},{"issue":"6","key":"10.1016\/j.xphs.2026.104209_bib0008","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.otc.2022.07.007","article-title":"Drooling and aspiration of saliva","volume":"55","author":"Hughes","year":"2022","journal-title":"Otolaryngol Clin North Am"},{"issue":"5","key":"10.1016\/j.xphs.2026.104209_bib0009","article-title":"Treatment for sialorrhea (excessive saliva) in people with motor neuron disease\/amyotrophic lateral sclerosis","volume":"5","author":"James","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xphs.2026.104209_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.encep.2025.02.004","article-title":"Treatment strategies for clozapine-induced sialorrhea in France: a systematic review","author":"Rousseau-Voisin","year":"2025","journal-title":"Enc\u00e9phale"},{"issue":"3","key":"10.1016\/j.xphs.2026.104209_bib0011","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/dmcn.14350","article-title":"Anticholinergic medications for reducing drooling in children with developmental disability","volume":"62","author":"Reid","year":"2020","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.xphs.2026.104209_bib0012","first-page":"19","article-title":"Sialorrhea in patients with ALS: current treatment options","volume":"9","author":"Garuti","year":"2019","journal-title":"Degener Neurol Neuromuscul Dis"},{"issue":"10","key":"10.1016\/j.xphs.2026.104209_bib0013","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/adc.88.10.911","article-title":"A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling","volume":"88","author":"Jongerius","year":"2003","journal-title":"Arch Dis Child"},{"issue":"1-2","key":"10.1016\/j.xphs.2026.104209_bib0014","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-510X(01)00631-1","article-title":"External radiation of the parotid glands significantly reduces drooling in patients with motor neurone disease with bulbar paresis","volume":"191","author":"Andersen","year":"2001","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1016\/j.xphs.2026.104209_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2024.104433","article-title":"Navigating the spectrum of pediatric sialorrhea management: a narrative review","volume":"45","author":"Kronlage","year":"2024","journal-title":"Am J Otolaryngol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104209_bib0016","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/pch\/pxab051","article-title":"Anticholinergic treatment for sialorrhea in children: a systematic review","volume":"27","author":"You","year":"2022","journal-title":"Paediatr Child Health"},{"issue":"12","key":"10.1016\/j.xphs.2026.104209_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.108050","article-title":"Sublingual administration of atropine eye drops for treating sialorrhea after stroke: a randomized controlled trial","volume":"33","author":"Wang","year":"2024","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"4","key":"10.1016\/j.xphs.2026.104209_bib0018","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/s-0043-1771457","article-title":"Constipation in Parkinson\u2019s disease","volume":"43","author":"Quigley","year":"2023","journal-title":"Semin Neurol"},{"issue":"6","key":"10.1016\/j.xphs.2026.104209_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27951","article-title":"Constipation in patients with motor neuron disease: a retrospective longitudinal study","volume":"10","author":"Yamamoto","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.xphs.2026.104209_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.74.1.13","article-title":"Constipation in neurological diseases","volume":"74","author":"Winge","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.xphs.2026.104209_bib0021","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/archdischild-2017-313763","article-title":"Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability","volume":"103","author":"Parr","year":"2018","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.xphs.2026.104209_bib0022","article-title":"Longitudinal CT evaluation of Transdermal scopolamine for aspiration pneumonia with sialorrhea in severe chronic brain injury: a case series","volume":"10","author":"Yamaki","year":"2022","journal-title":"Sage Open Med Case Rep"},{"issue":"1","key":"10.1016\/j.xphs.2026.104209_bib0023","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s12887-020-02336-x","article-title":"Efficacy of scopolamine transdermal patch in children with sialorrhea in a pediatric tertiary care hospital","volume":"20","author":"Al Jeraisy","year":"2020","journal-title":"BMC Pediatr"},{"issue":"12","key":"10.1016\/j.xphs.2026.104209_bib0024","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1248\/bpb.b23-00561","article-title":"Application site of transdermal scopolamine influences efficacy and drug concentration in salivary glands in rats","volume":"46","author":"Ishida","year":"2023","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10.1016\/j.xphs.2026.104209_bib0025","first-page":"6","article-title":"Pharmacologic management of sialorrhea in neonatal and pediatric patients","volume":"29","author":"Bradford","year":"2024","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.xphs.2026.104209_bib0026","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2165\/00003088-200645060-00001","article-title":"Transdermal scopolamine for prevention of motion sickness: clinical pharmacokinetics and therapeutic applications","volume":"45","author":"Nachum","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.xphs.2026.104209_bib0027","article-title":"Scopolamine (hyoscine) for preventing and treating motion sickness","volume":"6","author":"Spinks","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.xphs.2026.104209_bib0028","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1186\/s12903-024-04667-y","article-title":"Transdermal pilocarpine on the skin over salivary glands to increase salivation: an in vivo study","volume":"24","author":"Ishida","year":"2024","journal-title":"BMC Oral Health"},{"issue":"2","key":"10.1016\/j.xphs.2026.104209_bib0029","first-page":"42","article-title":"Effect of intramuscular medetomidine administration on tear flow in rats","volume":"7","author":"Kanda","year":"2020","journal-title":"Vet Sci"},{"issue":"4","key":"10.1016\/j.xphs.2026.104209_bib0030","first-page":"197","article-title":"Effect of different doses of atipamezole on reversal of medetomidine-induced tear-flow decrease in rats","volume":"7","author":"Kanda","year":"2020","journal-title":"Vet Sci"},{"issue":"7","key":"10.1016\/j.xphs.2026.104209_bib0031","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.3390\/ijms21072491","article-title":"Comparative study of constipation exacerbation by potassium binders using a loperamide-induced constipation model","volume":"21","author":"Narita","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.xphs.2026.104209_bib0032","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/02713683.2018.1434895","article-title":"Effects of menthol-containing artificial tears on tear stimulation and ocular surface integrity in normal and dry eye rat models","volume":"43","author":"Ahn","year":"2018","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104209_bib0033","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/WNF.0b013e31823dc125","article-title":"A comparison of cinnarizine and Transdermal scopolamine for the prevention of seasickness in naval crew: a double-blind, randomized, crossover study","volume":"35","author":"Gil","year":"2012","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104209_bib0034","first-page":"41","article-title":"Prevention and treatment of motion sickness","volume":"90","author":"Brainard","year":"2014","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.xphs.2026.104209_bib0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/jcm9010156","article-title":"The effect of a transdermal scopolamine patch on postoperative nausea and vomiting after retromastoid craniectomy with microvascular decompression: a preliminary single center, double-blind, randomized controlled trial","volume":"9","author":"Lee","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.xphs.2026.104209_bib0036","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fphar.2014.00055","article-title":"The effect of transdermal scopolamine for the prevention of postoperative nausea and vomiting","volume":"5","author":"Antor","year":"2014","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104209_bib0037","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bjoms.2018.01.014","article-title":"Transdermal scopolamine for the prevention of a salivary fistula after parotidectomy","volume":"56","author":"Mantsopoulos","year":"2018","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"4","key":"10.1016\/j.xphs.2026.104209_bib0038","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/019459989010300415","article-title":"Reduction of salivary flow with transdermal scopolamine: a four-year experience","volume":"103","author":"Talmi","year":"1990","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.xphs.2026.104209_bib0039","article-title":"Long-term regenerative potential of submandibular glands in albino rats following radiotherapy: role of cytokeratin 17 redistribution","volume":"17","author":"Hassan","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.xphs.2026.104209_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106587","article-title":"Effects of a supraphysiological dose of testosterone cypionate on salivary gland function in adult male Wistar rats","volume":"243","author":"Sampaio","year":"2024","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.xphs.2026.104209_bib0041","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neubiorev.2021.04.031","article-title":"Anticholinergic drugs and the risk of dementia: a systematic review and meta-analysis","volume":"127","author":"Zheng","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.xphs.2026.104209_bib0042","doi-asserted-by":"crossref","first-page":"k1315","DOI":"10.1136\/bmj.k1315","article-title":"Anticholinergic drugs and risk of dementia: case-control study","volume":"361","author":"Richardson","year":"2018","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.xphs.2026.104209_bib0043","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.disamonth.2011.05.006","article-title":"Constipation","volume":"57","author":"Deepak","year":"2011","journal-title":"Dis Mon"},{"issue":"6","key":"10.1016\/j.xphs.2026.104209_bib0044","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1159\/000506981","article-title":"Potentially inappropriate prescriptions for anticholinergic medications for patients with constipation","volume":"38","author":"Valladales-Restrepo","year":"2020","journal-title":"Dig Dis"},{"issue":"5","key":"10.1016\/j.xphs.2026.104209_bib0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/00002018-200831050-00002","article-title":"Drug-induced urinary retention: incidence, management and prevention","volume":"31","author":"Verhamme","year":"2008","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.xphs.2026.104209_bib0046","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/1573403X13666171129183826","article-title":"Challenges in treatment of inappropriate sinus tachycardia","volume":"14","author":"Ruzieh","year":"2018","journal-title":"Curr Cardiol Rev"},{"issue":"2","key":"10.1016\/j.xphs.2026.104209_bib0047","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/europace\/euy128","article-title":"Inappropriate sinus tachycardia","volume":"21","author":"Olshansky","year":"2019","journal-title":"Europace"},{"issue":"14","key":"10.1016\/j.xphs.2026.104209_bib0048","first-page":"2921","article-title":"The relationship between dry eye disease and anticholinergic burden","volume":"37","author":"Katipo\u011flu","year":"2023","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.xphs.2026.104209_bib0049","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/1346-8138.16188","article-title":"Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: a randomized, double-blind, vehicle-controlled study","volume":"49","author":"Yokozeki","year":"2022","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104209_bib0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0006-8993(92)90640-U","article-title":"Postinjury scopolamine administration in experimental traumatic brain injury","volume":"569","author":"Lyeth","year":"1992","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104209_bib0051","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13054-020-02915-5","article-title":"Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics","volume":"24","author":"Schulz","year":"2020","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.xphs.2026.104209_bib0052","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1093\/jat\/bkaa135","article-title":"Diminished consciousness in a woman following an unsuspected scopolamine overdose","volume":"45","author":"Barcel\u00f3","year":"2021","journal-title":"J Anal Toxicol"},{"issue":"7","key":"10.1016\/j.xphs.2026.104209_bib0053","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/00498254.2019.1703059","article-title":"Utility of hairless rats as a model for predicting transdermal pharmacokinetics in humans","volume":"50","author":"Yamamoto","year":"2020","journal-title":"Xenobiotica"},{"key":"10.1016\/j.xphs.2026.104209_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2019.104623","article-title":"Capacity of an in vitro rat skin model to predict human dermal absorption: influences of aging and anatomical site","volume":"61","author":"Marquet","year":"2019","journal-title":"Toxicol In Vitro"},{"issue":"1","key":"10.1016\/j.xphs.2026.104209_bib0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.archoralbio.2007.07.012","article-title":"Expression of muscarinic receptor subtypes in salivary glands of rats, sheep and man","volume":"53","author":"Ryberg","year":"2008","journal-title":"Arch Oral Biol"},{"issue":"5","key":"10.1016\/j.xphs.2026.104209_bib0056","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1267\/ahc.12013","article-title":"Anatomy and histology of rodent and human major salivary glands: -overview of the Japan salivary gland society-sponsored workshop","volume":"45","author":"Amano","year":"2012","journal-title":"Acta Histochem Cytochem"},{"issue":"3","key":"10.1016\/j.xphs.2026.104209_bib0057","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/15569527.2020.1787434","article-title":"Effects of anatomical location on in vivo percutaneous penetration in man","volume":"39","author":"Bormann","year":"2020","journal-title":"Cutan Ocul Toxicol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104209_bib0058","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10937404.2022.2032517","article-title":"Regional variation in percutaneous absorption in in vitro human models: a systematic review","volume":"25","author":"Gajewska","year":"2022","journal-title":"J Toxicol Environ Health B Crit Rev"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926000584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926000584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:40:02Z","timestamp":1777426802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926000584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0022354926000584"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104209","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted transdermal scopolamine delivery over the salivary glands for sialorrhea: Dose\u2013response and systemic safety in rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104209"}}